Whole abdominal radiotherapy in ovarian cancer

Reports of Practical Oncology and Radiotherapy

Volumn 15, Issue 2, 2010, Pages 27-30

  Biete, Alberto ^a   Valduvieco, Izaskun ^a   Rovirosa, Angels ^a   Farrús, Blanca ^a   Casas, Francesc ^a   Conill, Carlos ^a  

^a INSTITUT D INVESTIGACIONS BIOMÈDIQUES AUGUST PI I SUNYER IDIBAPS   (Spain)

Author keywords

Gastrointestinal toxicity; Ovarian cancer; Whole abdominal radiotherapy

Indexed keywords

CARBOPLATIN; CISPLATIN; CYCLOPHOSPHAMIDE; DOXORUBICIN;

ABDOMEN; ABDOMINAL RADIOTHERAPY; ACUTE TOXICITY; ADJUVANT THERAPY; ADULT; AGED; ARTICLE; BRAIN METASTASIS; CANCER ADJUVANT THERAPY; CANCER CONTROL; CANCER RECURRENCE; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CLINICAL ARTICLE; CYTOREDUCTIVE SURGERY; DISEASE FREE SURVIVAL; DISTANT METASTASIS; FEMALE; FOLLOW UP; GASTROINTESTINAL TOXICITY; HUMAN; LIVER METASTASIS; MULTIPLE CYCLE TREATMENT; OVARY CANCER; OVERALL SURVIVAL; PELVIS; RADIATION DOSE; SMALL INTESTINE OBSTRUCTION; TREATMENT OUTCOME;

EID: 77950916099     PISSN: 15071367     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.rpor.2010.02.004     Document Type: Article

References (23)

1. Jemal A., Siegel R., Ward E., et al. Cancer statistics, 2007. CA Cancer J. Clin. 57 (2007) 43-66
2. Guppy A.E., Nathan P.D., and Rustin G.J. Epithelial ovarian cancer: a review of current management. Clin. Oncol. (R. Coll. Radiol.) 17 (2005) 399-411
3. Gadducci A., and Cosio S. Surveillance procedures for patients treated for epithelial ovarian cancer: a review of literature. Int. J. Gynecol. Cancer 17 (2007) 21-31
4. Heintz A.P., Odicino F., Maisonneuve P., et al. Carcinoma of the ovary. FIGO Annual Report Editorial Office, European Institute of Oncology, via Ripamonti 435, 20141 Milan, Italy. Int. J. Gynecol. Obstet. 83 (2003) 135-166
5. Gasent J.M., Alberola V., Provencio M., Esteban E., and Martín S. Management of platinum-resistant ovarian cancer with the combination of pemetrexed and gemcitabine. Clin. Transl. Oncol. 11 (2009) 35-40
6. Dembo A.J., Bush R.S., Beale F.A., Bean H.A., Pringle J.F., and Sturgeon J.F. The Princess Margaret Hospital study of ovarian cancer: stages I, II, and asymptomatic III presentations. Cancer Treat. Rep. 63 (1979) 249-254
7. Dinniwell R., and Lock M. Consolidative abdominopelvic radiotherapy after surgery and carboplatino/paclitaxel chemotherapy for epithelial ovarian cancer. Int. J. Radiat. Oncol. Biol. Phys. 62 (2005) 104-110
8. Dembo A.J., and Bush R.S. Choice of postoperative therapy based on prognostic factors. Int. J. Radiat. Oncol. Biol. Phys. 8 (1982) 893-897
9. Fyles A.W., Dembo A.J., Bush R.S., et al. Analysis of complications in patients treated with abdomino-pelvic radiation therapy for ovarian carcinoma. Int. J. Radiat. Oncol. Biol. Phys. 22 (1992) 847-851
10. Cox J.D., Stetz J.A., and Pajak T.F. Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC). Int. J. Radiat. Oncol. Biol. Phys. 31 (1995) 1341-1346
11. Henríquez I., Castro D., Berenguer J., and Biete A. Calcification of presumed ovarian carcinoma brain metastases following radiotherapy. Br. J. Radiol. 72 (1999) 85-88
12. Smith J.P., and Rutledge F.N. Postoperative treatment of early cancer of ovary: a random trial between postoperative radiation and chemotherapy. Natl. Cancer Inst. Monogr. 42 (1975) 149-153
13. Dembo A.J. Epithelial ovarian cancer: the role of radiotherapy. Int. J. Radiat. Oncol. Biol. Phys. 22 (1992) 835-845
14. Hruby G., Bull C.A., Langlands A.O., et al. WART revisited: the treatment of epithelial ovarian cancer by whole abdominal radiotherapy. Aust. Radiol. 41 (1997) 276-280
15. McGuire Wp, Hoskins W.J., Brady M.F., et al. Cyclophosphamide and cisplatin compared with paclitaxel and cisplatin in patients with stage III and IV ovarian cancer. N. Engl. J. Med. 334 (1996) 1-6
16. Piccart M.J., Bertelsen K., James K., et al. Randomized intergroup trial of cisplatin-paclitaxel versus cisplatin-cyclophosphamide in women with advanced epithelial ovarian cancer: three-year results. J. Natl. Cancer Inst. 92 May (9) (2000) 699-708
17. Moss C., and Kaye S.B. Ovarian cancer: progress and continuing controversies in management. Eur. J. Cancer 38 (2002) 1701-1707
18. Goldberg N., and Peschel R.E. Postoperative abdominopelvic radiation therapy for ovarian cancer. Int. J. Radiat. Oncol. Biol. Phys. 14 March (3) (1988) 425-429
19. Lindner H., Willich H., and Atzinger A. Primary adjuvant whole abdominal irradiation in ovarian carcinoma. Int. J. Radiat. Oncol. Biol. Phys. 19 November (5) (1990) 1203-1206
20. Macbeth F.R., Macdonald H., and Williams C.J. Total abdominal and pelvic radiotherapy in the management of early stage ovarian carcinoma. Int. J. Radiat. Oncol. Biol. Phys. 15 August (2) (1988) 353-358
21. Firat S., Murray K., and Erickson B. High-dose whole abdominal and pelvic irradiation for treatment of ovarian carcinoma: long-term toxicity and outcomes. Int. J. Radiat. Oncol. Biol. Phys. 1 (2003) 201-207
22. Schray M.F., Martinez A., and Howes A.E. Toxicity of open-field whole abdominal irradiation as primary postoperative treatment in gynecologic malignancy. Int. J. Radiat. Oncol. Biol. Phys. 16 (1989) 397-403
23. Whelan T.J., Dembo A.J., Bush R.S., et al. Complications of whole abdominal and pelvic radiotherapy following chemotherapy for advanced ovarian cancer. Int. J. Radiat. Oncol. Biol. Phys. 22 (1992) 853-858